• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

CCE Prostate Cancer: Johns Hopkins by the numbers

Article

The numbers behind Johns Hopkins' Brady Urological Institute

The following data were evaluated to determine Johns Hopkins’ Brady Urological Institute’s standing as a Clinical Center of Excellence for prostate cancer:

1915 – Institute founded

27 – Faculty

24,500 – Number of patients treated/procedures performed in 2008

2,075 – Adult urology inpatientdischarges in 2008

291 – Research protocols in 2008

$5.6 million – Total amount of 11 National Institutes of Health grants allocated to Johns Hopkins in 2007 for urology research

 

Related Videos
Georges C. Benjamin, MD
Georges C. Benjamin, MD
Georges C. Benjamin, MD
Georges C. Benjamin, MD
Georges C. Benjamin, MD
Georges C. Benjamin, MD
Georges C. Benjamin, MD
© 2023 MJH Life Sciences

All rights reserved.